During the past decade, Ankara Baskent University Medicine Faculty; Gynaecology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ankara Baskent University Medicine Faculty; Gynaecology" are "Cervical Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Ankara Baskent University Medicine Faculty; Gynaecology" in a lesser frequency.

Most popular intervention types in "Ankara Baskent University Medicine Faculty; Gynaecology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Carboplatin" (1 trials), "Paclitaxel" (1 trials), "liposomal doxorubicin" (1 trials) and "paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ankara Baskent University Medicine Faculty; Gynaecology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ankara Baskent University Medicine Faculty; Gynaecology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ankara Baskent University Medicine Faculty; Gynaecology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ankara Baskent University Medicine Faculty; Gynaecology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".